FindTrial
Sign In

Ropivacaine substitution for lidocaine in postoperative pain management following mandibular third molar extraction

Ropivacaine substitution for lidocaine in postoperative pain management following mandibular third molar extraction

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600126459
Enrollment
Unknown
Registered
2026-06-09
Start date
2024-10-17
Completion date
Unknown
Last updated
2026-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative sequelae

Interventions

Observation group of post-extraction reaction:None

Sponsors

Affiliated Stomatological Hospital of Guangzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients requiring simple unilateral mandibular third molar extraction, aged 18 to 65 years, regardless of gender.

Exclusion criteria

Exclusion criteria: Patients with a history of systemic diseases (such as hypertension, heart disease, diabetes mellitus and other diseases that affect the prognosis of tooth extraction, or trigeminal neuralgia and other diseases that interfere with pain assessment), lactating patients or pregnant women, patients taking central nervous system depressants or any other analgesics, smokers, and patients allergic to local anesthetics or anti-inflammatory drugs.

Design outcomes

Primary

MeasureTime frame
Visual Analogue Scale;Postoperative Symptom Severity Scale;—

Secondary

MeasureTime frame
Numbness of lower lip;—

Countries

China

Contacts

Public ContactLibin Zhou

Affiliated Stomatological Hospital of Guangzhou Medical University

fmmumario@126.com+86 20 8197 8293

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 21, 2026